Clinicians need a more consistent and evidence-based approach to prescribing antipsychotics to children and adolescents with autism.

A panel of autism scientists and advocates is charged with a tall order: making recommendations for the care of autistic people worldwide.

Researchers say they are unimpressed with a study that underpins a tech company’s new digital therapy for autism.

Two drugs that alter the activity of the hormone vasopressin seem to improve social communication in autistic people, but some experts question the findings.

Serotonin, the brain chemical best known for its link to depression, may also be involved in autism.

Researchers are edging closer to a therapy for Angelman syndrome — a condition related to autism — that involves injecting the gene-editing enzyme CRISPR into the fetal brain.

The popularity of mobile devices offers families the promise of communication with their autistic child, but success is more than a click away.

Parents of autistic children are paying tens of thousands of dollars for stem cell therapies that often use medical waste. Despite the risks, regulators have been slow to act.

A much-touted behavioral therapy for autism, the Early Start Denver Model, may not be as effective as its creators had hoped.

Autism doesn’t just affect boys and men, but research on the condition still predominantly focuses on them. Some scientists are finally beginning to include women and nonbinary people in their studies.